<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151880">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01122849</url>
  </required_header>
  <id_info>
    <org_study_id>B3570674</org_study_id>
    <nct_id>NCT01122849</nct_id>
  </id_info>
  <brief_title>Exploratory Subjective Sleep Study of a Prototype Nasal Dilator</brief_title>
  <official_title>Exploratory Subjective Sleep Study of a Prototype Nasal Dilator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this exploratory study is to evaluate the subjective measures of congestion
      and sleep quality in subjects who suffer from chronic nasal congestion and report trouble
      with their sleep.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in responses to congestion and sleep questionnaire scores</measure>
    <time_frame>Baseline to day 14</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Sleep Disorders</condition>
  <condition>Congestion, Nasal</condition>
  <arm_group>
    <arm_group_label>Prototype Nasal Dilator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prototype Nasal Dilator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Marketed Nasal Strip</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Marketed Nasal Strip</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Nasal Strip</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prototype Nasal Dilator</intervention_name>
    <description>Prototype nasal dilator AB2R11</description>
    <arm_group_label>Prototype Nasal Dilator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Marketed Nasal Strip</intervention_name>
    <description>Breathe Right Nasal Strip- Clear small/medium</description>
    <arm_group_label>Marketed Nasal Strip</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo Nasal Strip</intervention_name>
    <description>Placebo strip</description>
    <arm_group_label>Placebo Nasal Strip</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with leptorrhine noses

          -  Subjects suffering from chronic nocturnal nasal congestion and report trouble with
             sleep
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>TKL Research Inc</name>
      <address>
        <city>Paramus</city>
        <state>New Jersey</state>
        <zip>07652</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Clinical Research Center</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 27, 2014</lastchanged_date>
  <firstreceived_date>May 11, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>trouble with sleep</keyword>
  <keyword>night time nasal congestion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
